skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 808  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: resource type: Newsletter Articles remove subject: Pharmaceutical Industry remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Aseptic meningitis alerts women in Durango: health authority warns about the use of a local anesthetic that caused the death of five young women and confirms other cases
Material Type:
Newsletter Article
Add to My Research

Aseptic meningitis alerts women in Durango: health authority warns about the use of a local anesthetic that caused the death of five young women and confirms other cases

CE Noticias Financieras, 2022

CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLC

Digital Resources/Online E-Resources

2
AMAG Pharmaceuticals Announces the Publication of the Phase 3 Vyleesi(TradeMark) (Bremelanotide Injection) Data in Obstetrics Gynecology
Material Type:
Newsletter Article
Add to My Research

AMAG Pharmaceuticals Announces the Publication of the Phase 3 Vyleesi(TradeMark) (Bremelanotide Injection) Data in Obstetrics Gynecology

News Bites - Healthcare & Equipment, 2019

Copyright News Bites Pty Ltd Oct 12, 2019

Digital Resources/Online E-Resources

3
HK Bourse: Announcement From Lees Pharmaceutical
Material Type:
Newsletter Article
Add to My Research

HK Bourse: Announcement From Lees Pharmaceutical

Dow Jones Institutional News, 2023

Copyright Dow Jones & Company Inc. Feb 16, 2023

Digital Resources/Online E-Resources

4
Phase 4 Study Demonstrates Superiority of EXPAREL plus Bupivacaine versus Bupivacaine Alone in Cesarean Section Procedures
Material Type:
Newsletter Article
Add to My Research

Phase 4 Study Demonstrates Superiority of EXPAREL plus Bupivacaine versus Bupivacaine Alone in Cesarean Section Procedures

News Bites - Healthcare & Equipment, 2019

Copyright News Bites Pty Ltd May 8, 2019

Digital Resources/Online E-Resources

5
Pacira Pharmaceuticals Phase 4 Study Demonstrates Superiority of EXPAREL plus Bupivacaine versus Bupivacaine Alone in Cesarean Section Procedures
Material Type:
Newsletter Article
Add to My Research

Pacira Pharmaceuticals Phase 4 Study Demonstrates Superiority of EXPAREL plus Bupivacaine versus Bupivacaine Alone in Cesarean Section Procedures

News Bites - Healthcare & Equipment, 2019

Copyright News Bites Pty Ltd May 8, 2019

Digital Resources/Online E-Resources

6
85% of women prefer instrumental method for voluntary termination of pregnancy, according to study
Material Type:
Newsletter Article
Add to My Research

85% of women prefer instrumental method for voluntary termination of pregnancy, according to study

CE Noticias Financieras, 2022

CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLC

Digital Resources/Online E-Resources

7
Four Women 'Die From Anesthesia' in Obstetrics Hospital
Material Type:
Newsletter Article
Add to My Research

Four Women 'Die From Anesthesia' in Obstetrics Hospital

AllAfrica.com, 2018

2018 AllAfrica Global Media. Provided by SyndiGate Media Inc. (Syndigate.info).

Digital Resources/Online E-Resources

8
Japan : Toray and ASKA Conclude Business Collaboration Agreement for Adhesion Barrier
Material Type:
Newsletter Article
Add to My Research

Japan : Toray and ASKA Conclude Business Collaboration Agreement for Adhesion Barrier

MENA Report, 2021

2021 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. (Syndigate.info). ;EISSN: 2219-0112

Digital Resources/Online E-Resources

9
Official attack against midwives
Material Type:
Newsletter Article
Add to My Research

Official attack against midwives

CE Noticias Financieras, 2023

CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLC

Digital Resources/Online E-Resources

10
There’s a new pill for postpartum depression, but many at-risk women face hurdles
Material Type:
Newsletter Article
Add to My Research

There’s a new pill for postpartum depression, but many at-risk women face hurdles

TCA News Service, 2024

2024 States Newsroom. Visit at stateline.org. Distributed by Tribune Content Agency, LLC.

Digital Resources/Online E-Resources

11
There's a new pill for postpartum depression, but many at-risk women face hurdles
Material Type:
Newsletter Article
Add to My Research

There's a new pill for postpartum depression, but many at-risk women face hurdles

TCA Regional News, 2024

(c)2024 Stateline.org Visit Stateline.org at www.stateline.org Distributed by Tribune Content Agency, LLC.

Digital Resources/Online E-Resources

12
Menopause under debate: analysis warns of excessive medicalization of this vital process
Material Type:
Newsletter Article
Add to My Research

Menopause under debate: analysis warns of excessive medicalization of this vital process

CE Noticias Financieras, 2024

CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLC

Digital Resources/Online E-Resources

13
Alliance Pharma (APH: GBX59.91) drops 3.5% weakening below moving average price; -GBX2.19 [-3.5%]
Material Type:
Newsletter Article
Add to My Research

Alliance Pharma (APH: GBX59.91) drops 3.5% weakening below moving average price; -GBX2.19 [-3.5%]

Company Data Report, 2023

Copyright News Bites Pty Ltd Mar 20, 2023

Digital Resources/Online E-Resources

14
Alliance Pharma (APH: GBX59.91) down 9.9% in 2 days; -GBX2.19 [-3.5%]
Material Type:
Newsletter Article
Add to My Research

Alliance Pharma (APH: GBX59.91) down 9.9% in 2 days; -GBX2.19 [-3.5%]

Company Data Report, 2023

Copyright News Bites Pty Ltd Mar 20, 2023

Digital Resources/Online E-Resources

15
HK Bourse: Announcement From Lees Pharmaceutical
Material Type:
Newsletter Article
Add to My Research

HK Bourse: Announcement From Lees Pharmaceutical

Dow Jones Institutional News, 2021

Copyright Dow Jones & Company Inc Jun 2, 2021

Digital Resources/Online E-Resources

16
Monthly: HCW Biologics (HCWB: $1.15) trails 80% of stocks
Material Type:
Newsletter Article
Add to My Research

Monthly: HCW Biologics (HCWB: $1.15) trails 80% of stocks

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd Feb 1, 2024

Digital Resources/Online E-Resources

17
HCW Biologics (HCWB: $1.11) slides 3.5% weakening below moving average price; -4c [-3.5%] Vol Index 1.4 [1 is avg]
Material Type:
Newsletter Article
Add to My Research

HCW Biologics (HCWB: $1.11) slides 3.5% weakening below moving average price; -4c [-3.5%] Vol Index 1.4 [1 is avg]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd Jan 26, 2024

Digital Resources/Online E-Resources

18
HCW Biologics (HCWB: $1.10) accelerates decline, down 5.2% in 2 days; -4.92c [-4.3%]
Material Type:
Newsletter Article
Add to My Research

HCW Biologics (HCWB: $1.10) accelerates decline, down 5.2% in 2 days; -4.92c [-4.3%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd Jan 20, 2024

Digital Resources/Online E-Resources

19
HCW Biologics (HCWB: $1.14) drops 1.7% weakening below moving average price; -2c [-1.7%]
Material Type:
Newsletter Article
Add to My Research

HCW Biologics (HCWB: $1.14) drops 1.7% weakening below moving average price; -2c [-1.7%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd Jan 19, 2024

Digital Resources/Online E-Resources

20
HCW Biologics (HCWB: $1.16) drops 1.7% weakening below moving average price; -2c [-1.7%]
Material Type:
Newsletter Article
Add to My Research

HCW Biologics (HCWB: $1.16) drops 1.7% weakening below moving average price; -2c [-1.7%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd Jan 17, 2024

Digital Resources/Online E-Resources

Results 1 - 20 of 808  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2005  (8)
  2. 2005 To 2008  (17)
  3. 2009 To 2012  (17)
  4. 2013 To 2017  (81)
  5. After 2017  (686)
  6. More options open sub menu

Searching Remote Databases, Please Wait